Archive · 18 Dec 2025
Trump's Drug Policy May Impact India's Pharma Trade
President Trump announced a new policy called 'Most Favoured Nation' to lower drug prices in the US.
He said he negotiated with drug companies and foreign countries to cut prices by a lot, up to 600%.
This policy will start in January and be available on a new website called TrumpRx.gov.
India's pharmaceutical companies, which supply many low-cost drugs to the US, will be affected.
Trump used the threat of tariffs to get other countries to help pay for these price cuts.
He also criticized health insurance companies, saying they should pass on the savings to people.
Indian drugmakers are worried about how this will affect their prices and their role in supplying affordable medicines to the US.
Trump announced a 'Most Favoured Nation' policy to cut US drug prices by up to 600%.
The policy will be implemented in January and available through TrumpRx.gov.
India's pharmaceutical companies, which supply many low-cost drugs to the US, will be impacted.
Trump used the threat of tariffs to pressure foreign countries to help pay for the price cuts.
Indian drugmakers are concerned about how the policy will affect their prices and their role in the US market.
- Who
- US President Donald Trump and Indian pharmaceutical companies
- What
- Announcement of a 'Most Favoured Nation' policy to cut US drug prices
- When
- Announced on Wednesday (local time), implementation in January
- Where
- United States, with implications for India
- Why
- To reduce decades of rising drug costs in the US and pressure foreign countries to absorb part of the cost
- Policy Name
- Most Favoured Nation
- Implementation Date
- January
- Website
- TrumpRx.gov
- Price Reduction Range
- 400-600%
- Key Pressure Tool
- Threat of tariffs
- Indian Pharma Role
- Supplies low-cost drugs to US
- Trump's Goal
- Lower US drug prices